Qvar and Multiple myeloma - a phase IV clinical study of FDA data

Summary:

Multiple myeloma is reported as a side effect among people who take Qvar (beclomethasone dipropionate), especially for people who are female, 50-59 old, also take Revlimid, and have Fatigue.

The phase IV clinical study analyzes which people have Multiple myeloma when taking Qvar. It is created by eHealthMe based on reports of 16,930 people who have side effects when taking Qvar from the FDA, and is updated regularly.

What is Qvar?

Qvar has active ingredients of beclomethasone dipropionate. It is often used in asthma. eHealthMe is studying from 17,355 Qvar users. Check the latest studies of Qvar.

What is Multiple myeloma?

Multiple myeloma (cancer of the plasma cells) is found to be associated with 1,107 drugs and 1,404 conditions by eHealthMe. Check the latest studies of Multiple myeloma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

16,930 people reported to have side effects when taking Qvar.
Among them, 30 people (0.18%) have Multiple myeloma.

Among these 30 people:

What is the gender of people who have Multiple myeloma when taking Qvar? *

female: 80 %
male: 20 %

What is the age of people who have Multiple myeloma when taking Qvar? *

What are other drugs people take besides Qvar? *

What are other side effects people have besides Multiple myeloma? *

High Blood Pressure: 22 people, 73.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 22 people, 73.33%
Weakness: 20 people, 66.67%
Emotional Distress: 19 people, 63.33%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 19 people, 63.33%
Pain In Jaw: 19 people, 63.33%
Pain: 19 people, 63.33%
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body): 19 people, 63.33%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 19 people, 63.33%
Oral Mucosa Atrophy (mucous membrane wasting of mouth): 19 people, 63.33%

What are the existing conditions these people have? *

High Blood Pressure: 19 people, 63.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 19 people, 63.33%
Fatigue (feeling of tiredness): 19 people, 63.33%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 6.67%
Nausea (feeling of having an urge to vomit): 1 person, 3.33%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Qvar and have Multiple myeloma?

- Check whether Multiple myeloma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Qvar:

Qvar (17,355 reports)

Multiple myeloma treatments and more:

Multiple myeloma (516,725 reports)

Browse all side effects of Qvar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple myeloma:

Multiple myeloma (1,107 drugs)

Browse all the conditions that are associated with Multiple myeloma:

Multiple myeloma (1,404 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on beclomethasone dipropionate (the active ingredients of Qvar) and Qvar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.